𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Efficacy and Safety of Once-Daily Linaclotide Administered Orally for 26 Weeks in Patients With IBS-C: Results From a Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial

✍ Scribed by William D. Chey; Anthony Lembo; James E. MacDougall; Bernard J. Lavins; Harvey Schneier; Jeffrey M. Johnston


Book ID
119432397
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
468 KB
Volume
140
Category
Article
ISSN
0016-5085

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Efficacy and safety of golimumab in pati
✍ Robert D. Inman; John C. Davis Jr.; DΓ©sirΓ©e Van Der Heijde; Laura Diekman; Joach πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 168 KB πŸ‘ 2 views

## Abstract ## Objective To evaluate the efficacy and safety of golimumab in patients with ankylosing spondylitis (AS) in the GO‐RAISE study. ## Methods Patients with active AS, a Bath AS Disease Activity Index (BASDAI) score β‰₯4, and a back pain score of β‰₯4 were randomly assigned in a 1.8:1.8:1